Table 3.
MPCs of Surfactin and Oxacillin in Combinations with Different Proportions for ATCC 25923 and Clinical MRSA Isolated from Patients with DFUs
| Strains | Oxacillin | Oxacillin+Surfactin (16 μg/mL) | Oxacillin+Surfactin (32 μg/mL) | Oxacillin+Surfactin (64 μg/mL) | |||||
|---|---|---|---|---|---|---|---|---|---|
| MIC | MPC | MIC/MPC | MPC | MIC/MPC | MPC | MIC/MPC | MPC | MIC/MPC | |
| ATCC 25923 | 0.5 | 16 | 32 | 1 | 16 | 0.5 | 8 | 0.25 | 4 |
| SA 452 | 8 | >256 | >32 | 16 | 64 | 8 | 32 | 4 | 16 |
Abbreviations: MIC, minimum inhibitory concentration; MPC, mutant prevention concentration.